S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
NASDAQ:CRON

Cronos Group (CRON) Stock Forecast, Price & News

$1.75
+0.05 (+2.94%)
(As of 06/6/2023 ET)
Compare
Today's Range
$1.66
$1.75
50-Day Range
$1.70
$2.04
52-Week Range
$1.66
$3.62
Volume
854,245 shs
Average Volume
1.47 million shs
Market Capitalization
$666.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.44

Cronos Group MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
96.4% Upside
$3.44 Price Target
Short Interest
Healthy
4.14% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.62mentions of Cronos Group in the last 14 days
Based on 5 Articles This Week
Insider Trading
Acquiring Shares
$434,250 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.13) to ($0.09) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.30 out of 5 stars

Medical Sector

237th out of 981 stocks

Medicinals & Botanicals Industry

1st out of 9 stocks


CRON stock logo

About Cronos Group (NASDAQ:CRON) Stock

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the United States and Rest of World segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

Receive CRON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter.

CRON Stock News Headlines

BREAKING: The truth about war with China
Foreign Affairs reports, "China is Now in a Prewar Tempo of Political and Military Preparations." China has one goal: take control of Taiwan, and an invasion could happen any day. I've identified 5 investments I believe are in immediate danger. But you can get out of them now - before it's too late.
"Unknown laser company making HUGE profit from Russia-Ukraine War"
On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>
Cronos Group (NASDAQ:CRON) Shares Up 4%
Cronos Group (NASDAQ:CRON) Rating Reiterated by Roth Capital
Morning News Call - Canada, May 9
Cronos Q1 2023 Revenue Declines 19.5% YoY, Provides Outlook
Earnings Outlook For Cronos Group
Closing Bell: Cronos Group Inc up on Friday (CRON)
Cronos Group (NASDAQ:CRON) Shares Gap Up to $1.73
See More Headlines

CRON Price History

CRON Company Calendar

Last Earnings
8/05/2021
Today
6/06/2023
Next Earnings (Estimated)
8/08/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Medicinals & botanicals
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CRON
Fax
N/A
Employees
626
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$3.44
High Stock Price Forecast
$4.75
Low Stock Price Forecast
$3.00
Forecasted Upside/Downside
+96.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
6 Analysts

Profitability

Net Income
$-168,730,000.00
Net Margins
-178.43%
Pretax Margin
-141.31%

Debt

Sales & Book Value

Annual Sales
$91.90 million
Book Value
$3.00 per share

Miscellaneous

Free Float
373,352,000
Market Cap
$666.44 million
Optionable
Optionable
Beta
1.48

Key Executives

  • Michael Ryan GorensteinMichael Ryan Gorenstein
    Chairman, President & Chief Executive Officer
  • James Holm
    Chief Financial Officer
  • Arye Weigensberg
    Head-Research & Technology
  • Jeffrey Jacobson
    Chief Growth Officer
  • Ran Gorelik
    General Manager-Israel













CRON Stock - Frequently Asked Questions

Should I buy or sell Cronos Group stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last twelve months. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CRON shares.
View CRON analyst ratings
or view top-rated stocks.

What is Cronos Group's stock price forecast for 2023?

6 Wall Street research analysts have issued 12 month price targets for Cronos Group's stock. Their CRON share price forecasts range from $3.00 to $4.75. On average, they expect the company's stock price to reach $3.44 in the next twelve months. This suggests a possible upside of 96.4% from the stock's current price.
View analysts price targets for CRON
or view top-rated stocks among Wall Street analysts.

How have CRON shares performed in 2023?

Cronos Group's stock was trading at $2.54 at the beginning of the year. Since then, CRON shares have decreased by 31.1% and is now trading at $1.75.
View the best growth stocks for 2023 here
.

Are investors shorting Cronos Group?

Cronos Group saw a decrease in short interest during the month of May. As of May 15th, there was short interest totaling 8,230,000 shares, a decrease of 12.6% from the April 30th total of 9,420,000 shares. Based on an average daily volume of 1,490,000 shares, the short-interest ratio is currently 5.5 days. Currently, 4.1% of the company's stock are sold short.
View Cronos Group's Short Interest
.

When is Cronos Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023.
View our CRON earnings forecast
.

How were Cronos Group's earnings last quarter?

Cronos Group Inc. (NASDAQ:CRON) announced its quarterly earnings data on Thursday, August, 5th. The company reported $0.15 earnings per share for the quarter, beating analysts' consensus estimates of ($0.07) by $0.22. The company had revenue of $15.60 million for the quarter, compared to the consensus estimate of $18.48 million. Cronos Group had a negative trailing twelve-month return on equity of 9.65% and a negative net margin of 178.43%. The business's revenue for the quarter was up 57.6% on a year-over-year basis. During the same quarter last year, the company posted ($0.31) earnings per share.

What guidance has Cronos Group issued on next quarter's earnings?

Cronos Group updated its FY 2023 earnings guidance on Tuesday, May, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $100.00 million-$110.00 million, compared to the consensus revenue estimate of $102.93 million.

What other stocks do shareholders of Cronos Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Aurora Cannabis (ACB), Tilray (TLRY), NVIDIA (NVDA), Advanced Micro Devices (AMD), Dollar Tree (DLTR), Micron Technology (MU), Alibaba Group (BABA) and Organigram (OGI).

What is Cronos Group's stock symbol?

Cronos Group trades on the NASDAQ under the ticker symbol "CRON."

Who are Cronos Group's major shareholders?

Cronos Group's stock is owned by a number of retail and institutional investors. Top institutional investors include ETF Managers Group LLC (1.45%), Dimensional Fund Advisors LP (0.39%), Intact Investment Management Inc. (0.30%), Mirae Asset Global Investments Co. Ltd. (0.26%), Penserra Capital Management LLC (0.14%) and Swiss National Bank (0.12%). Insiders that own company stock include Jason Marc Adler, Michael Ryan Gorenstein and Todd Kevin Abraham.
View institutional ownership trends
.

How do I buy shares of Cronos Group?

Shares of CRON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cronos Group's stock price today?

One share of CRON stock can currently be purchased for approximately $1.75.

How much money does Cronos Group make?

Cronos Group (NASDAQ:CRON) has a market capitalization of $666.44 million and generates $91.90 million in revenue each year. The company earns $-168,730,000.00 in net income (profit) each year or ($0.41) on an earnings per share basis.

How many employees does Cronos Group have?

The company employs 626 workers across the globe.

How can I contact Cronos Group?

Cronos Group's mailing address is 111 PETER STREET SUITE 300, TORONTO A6, M5V 2G9. The official website for the company is www.thecronosgroup.com. The company can be reached via phone at (416) 504-0004.

This page (NASDAQ:CRON) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -